Dr Ngwewondo Adela is a holder of a Ph.D. in Biochemistry from the University of Buea since 2019 and has keen interest in drugs and diagnostic research. The WHO/TDR Clinical Research and Development Fellowship was just the right opportunity to foster her understanding of the Drug Discovery and Development pipeline. She actively led the writing of an expert review while actively taking part in the two clinical trials on Emodepside and Flubentylosin at DNDi Geneva Switzerland. Her focus is to work towards the discovery of new therapeutic options and diagnostic biomarkers for onchocerciasis, schistosomiasis and has authored 7 publications.
Title : Onchocerciasis drug development: From pre-clinicals to humans